InspireMD, Inc. (NSPR): Entry into a Material Definitive Agreement
InspireMD, Inc. (NSPR) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 InspireMD Announces Pricing of $37.5 Million Public Offering Miami, FL -- November 13, 2026 — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the pricing


